BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6800421)

  • 21. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VIII-related antigen. A pericellular matrix component of cultured human endothelial cells.
    Hormia M; Lehto VP; Virtanen I
    Exp Cell Res; 1983 Dec; 149(2):483-97. PubMed ID: 6315462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of factor VIII complex properties in patients with liver disease.
    Maisonneuve P; Sultan Y
    J Clin Pathol; 1977 Mar; 30(3):221-7. PubMed ID: 300380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The separation of Willebrand factor from factor VIII-related antigen.
    Barrow ES; Reisner HM; Graham JB
    Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement therapy in platelet-type von Willebrand disease.
    Takahashi H
    Am J Hematol; 1985 Apr; 18(4):351-62. PubMed ID: 3919572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a simple visual assay of Willebrand factor for diagnosis and carrier identification.
    Reisner HM; Katz HJ; Goldin LR; Barrow ES; Graham JB
    Br J Haematol; 1978 Oct; 40(2):339-50. PubMed ID: 309339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
    Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
    Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.
    Lombardi R; Mannucci PM; Seghatchian MJ; Garcia VV; Coppola R
    Br J Haematol; 1981 Sep; 49(1):61-8. PubMed ID: 6791681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential localisation and synthesis of porcine factor VIII related antigen (VIIIR:AG) in vascular endothelium and in endothelial cells in culture.
    Giddings JC; Jarvis AL; Bloom AL
    Thromb Res; 1983 Feb; 29(3):299-312. PubMed ID: 6405500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor VIII complex in myelomatosis and related disorders.
    Leone G; Valori VM; Zini G; Bavaro P; Bartoloni C; Bizzi B
    Ric Clin Lab; 1982; 12(4):581-8. PubMed ID: 6818670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases.
    Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D
    Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules.
    Giddings JC; Brookes LR; Piovella F; Bloom AL
    Br J Haematol; 1982 Sep; 52(1):79-88. PubMed ID: 6810914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
    Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
    Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VIII related antigen in term and preterm newborns with severe neonatal haemorrhage.
    Balla G; Karmazsin L
    Acta Paediatr Hung; 1985; 26(1):11-5. PubMed ID: 3921043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease.
    Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ
    J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Von Willebrand factor multimer patterns in von Willebrand's disease.
    Hoyer LW; Rizza CR; Tuddenham EG; Carta CA; Armitage H; Rotblat F
    Br J Haematol; 1983 Nov; 55(3):493-507. PubMed ID: 6416288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of carrier detection in haemophilia A by linear discriminant function.
    Shen MC
    Br J Haematol; 1982 Oct; 52(2):283-93. PubMed ID: 6812614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.